GENE ONLINE|News &
Opinion
Blog

2020-08-19| R&DSpecialTechnology

A Novel Tool to Augment Checkpoint Inhibitor Cancer Therapy

by Ruchi Jhonsa
Share To
Washington University School of Medicine researchers uncover the mechanism by which tumor-infiltrating myeloid cells create suppressive microenvironments. The findings provide a novel approach for augmenting the effects of checkpoint blockade therapies. The suppressive tumor environment affects T cell responses by engaging immune checkpoint proteins such as PD-1.

GO Prime with only $1.49 now

LATEST
Previewing AACR 2024 With Select Pre-Meeting Highlights
2024-03-28
Roche Delivering on Malaria Screening Solutions for Blood Donation
2024-03-28
Innovating Cancer Treatment: The Role of ADC Technology at Nona Biosciences
2024-03-28
BIO CHINA 2024 Brings Biotech Experts and Industry Elites Together for Innovation
2024-03-27
Galderma’s Strong European IPO Debut
2024-03-26
Markets and Mergers: Boston Scientific and Axonics Shake Hands on Deal
2024-03-25
Discover the Next Billion-Dollar Unicorn at the Biotech Innovation Funding Networking Event
2024-03-21
EVENT
2024-04-06
Biotech Innovation Funding Networking
Los Angeles, USA
Scroll to Top